Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 42

Trial Status

Completed2
Other1

Role Distribution

Other Roles3

Activity Timeline

Clinical Trials (3)

NCT06331702Phase 4Completed
Immunogenicity of Japanese Encephalitis Vaccine Co-administered With Measles-Mumps-Rubella Vaccine (MMR)
Japanese EncephalitisMeaslesMumps+1 more
StudydirectorStart date: 2024-03-02
NCT06825312Phase 4Active Not Recruiting
Immunogenicity, Safety, and Antibody Persistence of Different Immunization Strategies Against Japanese Encephalitis
Japanese Encephalitis Vaccine
StudydirectorStart date: 2023-11-11

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Liaoning Chengda Biotechnology CO., LTD

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Srilatha Edupuganti, MD

Emory University

Related
2 trials

Shared therapeutic areas:

MeaslesMumpsRubella
Similarity Score18%

Carl T. D'Angio, MD

University of Rochester

Related
3 trials

Shared therapeutic areas:

MumpsRubellaMeasles
Similarity Score18%

Zijian Feng, MD, MPH

Centers for Disease Control and Prevention, China

Related
3 trials

Shared therapeutic areas:

Encephalitis, JapaneseMeaslesRubella

Worked with same sponsors:

Zhejiang Provincial Center for Disease Control and Prevention
Similarity Score18%

Anne Fiquet, MD

SPMSD

Related
4 trials

Shared therapeutic areas:

MeaslesMumpsRubella
Similarity Score18%

Huaqing Wang, MD, PhD

Centers for Disease Control and Prevention, China

Related
2 trials

Shared therapeutic areas:

Encephalitis, JapaneseMeaslesRubella

Worked with same sponsors:

Zhejiang Provincial Center for Disease Control and Prevention
Similarity Score18%

Zhijie An, MD, MPH

Centers for Disease Control and Prevention, China

Related
2 trials

Shared therapeutic areas:

Encephalitis, JapaneseMeaslesRubella

Worked with same sponsors:

Zhejiang Provincial Center for Disease Control and Prevention
Similarity Score18%

Odile Launay, MD, PhD

Assistance Publique - Hôpitaux de Paris

Related
3 trials

Shared therapeutic areas:

MeaslesMumpsRubella
Similarity Score18%

Eva Netterlid

Swedish Institute for Infectious Disease Control

Related
2 trials

Shared therapeutic areas:

MeaslesMumpsRubella
Similarity Score18%

Anu Kantele, MD PhD

Helsinki University Central Hospital

Related
2 trials

Shared therapeutic areas:

Encephalitis, Japanese
Similarity Score6%

Xing Fang

Liaoning Provincial Center for Disease Control and Prevention

Related
3 trials

Shared therapeutic areas:

Encephalitis, Japanese

Worked with same sponsors:

Liaoning Chengda Biotechnology CO., LTD
Similarity Score6%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT06331702Phase 4StudyDirector

Immunogenicity of Japanese Encephalitis Vaccine Co-administered With Measles-Mumps-Rubella Vaccine (MMR)

Japanese EncephalitisMeaslesMumps+1 more
Completed
NCT06372665StudyDirector

Safety Observation of the Japanese Encephalitis Vaccine Given With a Primary Immunization

Japanese Encephalitis
Completed
NCT06825312Phase 4StudyDirector

Immunogenicity, Safety, and Antibody Persistence of Different Immunization Strategies Against Japanese Encephalitis

Japanese Encephalitis Vaccine
Active Not Recruiting

All 3 trials loaded